We Think Cogent Biosciences (NASDAQ:COGT) Can Afford To Drive Business Growth [Yahoo! Finance]
Cogent Biosciences, Inc. (NASDAQ: COGT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $19.00 price target on the stock.
Cogent Biosciences, Inc. (NASDAQ: COGT) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $18.00 price target on the stock.
Cogent Biosciences Reports First Quarter 2024 Financial Results [Yahoo! Finance]
Cogent Biosciences Reports First Quarter 2024 Financial Results